drugset / Trial / NCT06443463
Long-term Safety and Tolerability of BHV-7000
Non-randomizedParallel-groupOpen-labelTreatment
Summary
A study to determine if BHV- 7000 is safe and tolerable in adults with refractory focal onset epilepsy
Timeline
- Start
- 2024-07-30
- Primary completion
- 2026-12
- Completion
- 2027-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BHV-7000 | Unknown | 50 mg | — |
| Subject | BHV-7000 | Unknown | 75 mg | — |